You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Correction: Overall survival at 5 years of follow-up in a phase III trial comparing ipilimumab 10 mg/kg with 3 mg/kg in patients with advanced melanoma

Article metrics

Article menu

Download PDFPDF

XML
Correction
Correction: Overall survival at 5 years of follow-up in a phase III trial comparing ipilimumab 10 mg/kg with 3 mg/kg in patients with advanced melanoma

 

Online download statistics by month:

Online download statistics by month: July 2020 to March 2024

AbstractFullPdf
Jul 2020016635
Aug 20200193
Sep 20200277
Oct 20200155
Nov 20200115
Dec 2020081
Jan 20210144
Feb 2021083
Mar 2021096
Apr 20210145
May 2021034
Jun 20210214
Jul 20210124
Aug 2021063
Sep 2021034
Oct 20210414
Nov 20210313
Dec 2021051
Jan 2022062
Feb 2022051
Mar 2022095
Apr 20220125
May 20220168
Jun 20220225
Jul 2022071
Aug 20220153
Sep 2022095
Oct 202201812
Nov 2022041
Dec 2022051
Jan 2023053
Feb 20230300
Mar 2023053
Apr 2023022
May 2023073
Jun 2023020
Jul 2023044
Aug 2023034
Sep 20230514
Oct 2023023
Nov 2023072
Dec 20230172
Jan 20240123
Feb 2024061
Mar 20240818
Total0591232